We Can Medicines Co., Ltd. (TPEX:6929)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.10
+0.10 (0.37%)
Apr 29, 2026, 1:17 PM CST
-16.23%
Market Cap 1.22B
Revenue (ttm) 3.22B
Net Income (ttm) -73.21M
Shares Out 45.07M
EPS (ttm) -1.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,370
Average Volume 9,989
Open 26.00
Previous Close 27.00
Day's Range 26.00 - 27.10
52-Week Range 26.00 - 36.60
Beta -0.38
RSI 32.82
Earnings Date May 8, 2026

About We Can Medicines

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd. [Read more]

Industry Packaged Foods
Founded 1972
Employees 1,005
Stock Exchange Taipei Exchange
Ticker Symbol 6929
Full Company Profile

Financial Performance

In 2025, We Can Medicines's revenue was 3.22 billion, a decrease of -1.45% compared to the previous year's 3.27 billion. Losses were -73.21 million, 55.2% more than in 2024.

Financial Statements

News

There is no news available yet.